This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Oct:60:102998.

doi: 10.1016/j.ebiom.2020.102998. Epub 2020 Sep 22.

"Dual use": The anti-allergy vaccine BM32 and its HBV carrier protein

Wolfram H Gerlich¹

Affiliations

Affiliation

¹ Institute for Medical Virology, Justus Liebig University Giessen, Schubert Str. 81, Giessen D35392, Germany. Electronic address: wolfram.h.gerlich@viro.med.uni-giessen.de.

PMID: 32977164
PMCID: PMC7516070
DOI: 10.1016/j.ebiom.2020.102998

"Dual use": The anti-allergy vaccine BM32 and its HBV carrier protein

Wolfram H Gerlich. EBioMedicine. 2020 Oct.

. 2020 Oct:60:102998.

doi: 10.1016/j.ebiom.2020.102998. Epub 2020 Sep 22.

Author

Wolfram H Gerlich¹

Affiliation

¹ Institute for Medical Virology, Justus Liebig University Giessen, Schubert Str. 81, Giessen D35392, Germany. Electronic address: wolfram.h.gerlich@viro.med.uni-giessen.de.

PMID: 32977164
PMCID: PMC7516070
DOI: 10.1016/j.ebiom.2020.102998

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Dr. Gerlich has nothing to disclose.

Similar articles

Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32.
Tulaeva I, Cornelius C, Zieglmayer P, Zieglmayer R, Schmutz R, Lemell P, Weber M, Focke-Tejkl M, Karaulov A, Henning R, Valenta R. Tulaeva I, et al. EBioMedicine. 2020 Sep;59:102953. doi: 10.1016/j.ebiom.2020.102953. Epub 2020 Aug 24. EBioMedicine. 2020. PMID: 32855110 Free PMC article.
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.
Cornelius C, Schöneweis K, Georgi F, Weber M, Niederberger V, Zieglmayer P, Niespodziana K, Trauner M, Hofer H, Urban S, Valenta R. Cornelius C, et al. EBioMedicine. 2016 Sep;11:58-67. doi: 10.1016/j.ebiom.2016.07.023. Epub 2016 Aug 8. EBioMedicine. 2016. PMID: 27568223 Free PMC article.
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines.
Weber M, Niespodziana K, Linhart B, Neubauer A, Huber H, Henning R, Valenta R, Focke-Tejkl M. Weber M, et al. J Allergy Clin Immunol. 2017 Nov;140(5):1433-1436.e6. doi: 10.1016/j.jaci.2017.03.048. Epub 2017 May 31. J Allergy Clin Immunol. 2017. PMID: 28576673 Free PMC article. No abstract available.
Immunological mechanisms of specific immunotherapy with pollen vaccines: implications for diagnostics and the development of improved vaccination strategies.
Movérare R. Movérare R. Expert Rev Vaccines. 2003 Feb;2(1):85-97. doi: 10.1586/14760584.2.1.85. Expert Rev Vaccines. 2003. PMID: 12901600 Review.
Hypothesis: Could Hepatitis B vaccine act as an immune adjuvant in glioblastoma? Clues to conduct further epidemiological analyses.
Altinoz MA, Ozpinar A, Ozpinar A, Hacker E, Elmaci İ. Altinoz MA, et al. Int Immunopharmacol. 2020 Apr;81:106038. doi: 10.1016/j.intimp.2019.106038. Epub 2019 Nov 19. Int Immunopharmacol. 2020. PMID: 31757678 Review.

See all similar articles

Cited by

The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines.
Tulaeva I, Lehmann F, Goldmann N, Dubovets A, Trifonova D, Tulaev M, Cornelius C, Weber M, Focke-Tejkl M, Karaulov A, Henning R, Springer DN, Wiedermann U, Glebe D, Valenta R. Tulaeva I, et al. Vaccines (Basel). 2024 Sep 30;12(10):1123. doi: 10.3390/vaccines12101123. Vaccines (Basel). 2024. PMID: 39460290 Free PMC article.
Virus-like Particles as Vaccines for Allergen-Specific Therapy: An Overview of Current Developments.
Berreiros-Hortala H, Vilchez-Pinto G, Diaz-Perales A, Garrido-Arandia M, Tome-Amat J. Berreiros-Hortala H, et al. Int J Mol Sci. 2024 Jul 6;25(13):7429. doi: 10.3390/ijms25137429. Int J Mol Sci. 2024. PMID: 39000536 Free PMC article. Review.

References

1. Tulaeva I., Cornelius C., Zieglmayer P. Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32. EBioMedicine. 2020 doi: 10.1016/j.ebiom.2020.102953. - DOI - PMC - PubMed
1. Cornelius C., Schöneweis K., Georgi F. Immunotherapy with the preS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection. EBioMedicine. 2016;11:58–67. - PMC - PubMed
1. Niespodziana K., Focke-Tejkl M., Linhart B. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. J Allergy Clin Immunol. 2011;127:1562–1570. - PMC - PubMed
1. Gerlich W.H., Glebe D., Kramvis A., Magnius L.O. Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings. Virus Genes. 2020;56:109–119. - PMC - PubMed
1. WHO. Global Hepatitis Report2017. [accessed on August 16, 2020]. Available from: http://www.who.int/hepatitis/publications/global-hepatitisreport2017/en/

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information